New biomarkers predict accelerated diabetic eye disease

In younger patients with type 2 diabetes, diabetic retinopathy is higher risk for them and should be monitored and checked for such risks. It is shown in over half of the study group and should not be taken lightly no matter how young the patient is. Their cells also seem to be aging rapidly, another growing cause among the generation.

Key Takeaways:

  • Retinopathy no longer a late complication of diabetes. Type 2 diabetes patients possess an increased risk of developing diabetic retinopathy at an earlier stage – with elevated levels of certain biomarkers such as 1 (MCP-1) and cathepsin-D.
  • Type 2 diabetes in younger adults and Asian Indians, with increasing trend, are highly prone to diabetic retinopathy. Study has reported a prevalence of almost 52% in diabetic patients diagnosed with early onset of the disease.
  • It is expected that targeting the pathways related to these biomarkers could be a future strategy for preventing the heightened risk of developing diabetic retinopathy in young-onset diabetic patients.

“Diabetes can lead to a wide variety of health complications, including heart disease, nerve damage, stroke, kidney disease, and vision loss.”